MedTrace Logo

Determining the Clinical Utility of Using Virtual Reality Headsets to Assess Visual Function in Those With Glaucoma.

NCT04273438 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2020-02-24

No results posted yet for this study

Summary

To validate a new virtual reality (VR) based visual field test against the gold standard clinical perimetry test (Humphrey Visual field test 24-2).

Conditions

Interventions

DEVICE

Visual field testing using Oculus Rift and Humphrey Visual Field Perimeter

Glaucoma patients at Queen's University, Belfast, will be invited to undergo both Visual field testing using the Oculus Rift and the gold-standard Humphrey 24-2 (Carl Zeiss Meditec, Dublin, CA) at two visits, and evaluating consistency for detecting visual field impairments.

DEVICE

Visual Field Testing using HUmphrey 24-3 Perimeter

Glaucoma patients at Queen's University, Belfast, will be invited to undergo both Visual field testing using the Oculus Rift and the gold-standard Humphrey 24-2 (Carl Zeiss Meditec, Dublin, CA) at two visits, and evaluating consistency for detecting visual field impairments.

Sponsors & Collaborators

  • University of Sussex

    collaborator OTHER

  • Queen's University, Belfast

    lead OTHER

Principal Investigators

  • Ruth E Hogg, PhD · Queen's University, Belfast

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2020-09-30
Completion
2020-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04273438 on ClinicalTrials.gov